312 related articles for article (PubMed ID: 21845090)
1. Epigenetic therapy for breast cancer.
Cai FF; Kohler C; Zhang B; Wang MH; Chen WJ; Zhong XY
Int J Mol Sci; 2011; 12(7):4465-87. PubMed ID: 21845090
[TBL] [Abstract][Full Text] [Related]
2. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
Oh S; Ko JY; Oh C; Yoo KH
Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
[TBL] [Abstract][Full Text] [Related]
4. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
5. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the potential of epigenetic therapy to target solid tumors.
Ahuja N; Easwaran H; Baylin SB
J Clin Invest; 2014 Jan; 124(1):56-63. PubMed ID: 24382390
[TBL] [Abstract][Full Text] [Related]
7. Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies.
Lee E; Koh Y; Hong J; Eom HS; Yoon SS
J Korean Med Sci; 2021 Apr; 36(13):e85. PubMed ID: 33821592
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic therapies in patients with solid tumors: Focus on monotherapy with deoxyribonucleic acid methyltransferase inhibitors and histone deacetylase inhibitors.
Katarzyna R; Lucyna B
J Cancer Res Ther; 2019; 15(5):961-970. PubMed ID: 31603095
[TBL] [Abstract][Full Text] [Related]
9. Current limitations and future opportunities for epigenetic therapies.
Cherblanc F; Chapman-Rothe N; Brown R; Fuchter MJ
Future Med Chem; 2012 Mar; 4(4):425-46. PubMed ID: 22416773
[TBL] [Abstract][Full Text] [Related]
10. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors.
Teixeira SR; Abreu CM; Parkes L; Davies J; Yao S; Sawhney MA; Margarit L; Gonzalez D; Pinto IM; Francis LW; Conlan RS
Biosens Bioelectron; 2019 Sep; 141():111386. PubMed ID: 31220725
[TBL] [Abstract][Full Text] [Related]
11. Melanoma epigenetics: novel mechanisms, markers, and medicines.
Lee JJ; Murphy GF; Lian CG
Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.
Walsh L; Gallagher WM; O'Connor DP; Ní Chonghaile T
Expert Rev Mol Diagn; 2016; 16(5):541-51. PubMed ID: 26895288
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
[TBL] [Abstract][Full Text] [Related]
14. The role of epigenetics in malignant pleural mesothelioma.
Vandermeers F; Neelature Sriramareddy S; Costa C; Hubaux R; Cosse JP; Willems L
Lung Cancer; 2013 Sep; 81(3):311-318. PubMed ID: 23790315
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
Shukla S; Penta D; Mondal P; Meeran SM
Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs.
Yu J; Xie T; Wang Z; Wang X; Zeng S; Kang Y; Hou T
Drug Discov Today; 2019 Dec; 24(12):2323-2331. PubMed ID: 31494187
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic targeting in breast cancer: therapeutic impact and future direction.
Lustberg MB; Ramaswamy B
Drug News Perspect; 2009 Sep; 22(7):369-81. PubMed ID: 19890494
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapy of cancer: past, present and future.
Yoo CB; Jones PA
Nat Rev Drug Discov; 2006 Jan; 5(1):37-50. PubMed ID: 16485345
[TBL] [Abstract][Full Text] [Related]
19. Prospects for epigenetic compounds in the treatment of autoimmune disease.
Chapman-Rothe N; Brown R
Adv Exp Med Biol; 2011; 711():150-61. PubMed ID: 21627048
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modifications as therapeutic targets.
Kelly TK; De Carvalho DD; Jones PA
Nat Biotechnol; 2010 Oct; 28(10):1069-78. PubMed ID: 20944599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
